Literature DB >> 32059829

The Comprehensive Care Plan: A Patient-Centered, Multidisciplinary Communication Tool for Frequently Hospitalized Patients.

Maria E Theodorou, Bruce L Henschen, Margaret Chapman.   

Abstract

Comprehensive care plans are dynamic documents maintained by an interdisciplinary team that contain specific, actionable information for clinicians and staff across multiple care settings. They promote communication and continuity of care by suggesting communication strategies, medical plans, and psychosocial resources. This article describes the structure and development process of comprehensive care plans for frequently hospitalized patients enrolled in a program designed to improve care for this vulnerable population. These care plans are widely used, with inpatient physicians referring to the care plan in their notes during 92.0% of admissions.
Copyright © 2020 The Joint Commission. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 32059829     DOI: 10.1016/j.jcjq.2020.01.002

Source DB:  PubMed          Journal:  Jt Comm J Qual Patient Saf        ISSN: 1553-7250


  3 in total

1.  An Intensive Intervention to Reduce Readmissions for Frequently Hospitalized Patients: the CHAMP Randomized Controlled Trial.

Authors:  Bruce L Henschen; Maria E Theodorou; Margaret Chapman; McKay Barra; Abby Toms; Kenzie A Cameron; Shuhan Zhou; Chen Yeh; Jungwha Lee; Kevin J O'Leary
Journal:  J Gen Intern Med       Date:  2021-09-01       Impact factor: 6.473

2.  Primary care physician involvement during hospitalisation: a qualitative analysis of perspectives from frequently hospitalised patients.

Authors:  Erin Yildirim Rieger; Josef N S Kushner; Veena Sriram; Abbie Klein; Lauren O Wiklund; David O Meltzer; Joyce W Tang
Journal:  BMJ Open       Date:  2021-12-01       Impact factor: 2.692

3.  A Comprehensive Nursing Model Combined with High-Quality Nursing Intervention for Antiviral Therapy in Patients with Chronic Hepatitis B.

Authors:  Wei Yang; Xiaofeng Tian; Jing Liang
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-08       Impact factor: 2.650

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.